Literature DB >> 18064407

Mutation-prone points in thrombin receptor.

Viroj Wiwanitkit1.   

Abstract

BACKGROUND: Thrombin receptor (TR) is a G-protein-coupled receptor that transmits cellular responses to coagulant proteases in a variety of cell types in the vasculature and other tissues. Mutation within TR can be seen. Presently, the prediction of protein nanostructure and function is a great challenge in the proteomics and structural genomics era.
METHODS: To identify the points vulnerable to mutation is a new trend directed at expanding the knowledge on disorders in genomic and proteomic levels of diseases. In this paper, the author performed a bioinformatics analysis to find the mutation-prone positions in the amino acid sequence of TR. To identify those points in TR, a new bioinformatics tool, namely, GlobPlot was used.
RESULTS: According to this work, no position was identified to be resistant to mutation.
CONCLUSION: This means that TR is a very highly genetically unstable molecule. Thousands of types of mutation can be expected. Of interest, only a few sense mutations are mentioned in clinical settings. Therefore, many occulted sense mutations might still be detected.

Mesh:

Substances:

Year:  2007        PMID: 18064407     DOI: 10.1007/s11239-007-0167-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  28 in total

Review 1.  Orthologs, paralogs and genome comparisons.

Authors:  J P Gogarten; L Olendzenski
Journal:  Curr Opin Genet Dev       Date:  1999-12       Impact factor: 5.578

2.  The -5061/D polymorphism of the thrombin receptor (PAR-1) gene is not related to myocardial infarction in the ECTIM study. The Etude Cas-Temoins de l'Infarctus du Myocarde. MONICA Members Group.

Authors:  E Arnaud; O Poirier; M Aiach; F Cambien
Journal:  Thromb Haemost       Date:  2000-10       Impact factor: 5.249

3.  A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins.

Authors:  Rune Linding; Joost Schymkowitz; Frederic Rousseau; Francesca Diella; Luis Serrano
Journal:  J Mol Biol       Date:  2004-09-03       Impact factor: 5.469

Review 4.  The measurement and application of thrombin generation.

Authors:  Trevor Baglin
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

Review 5.  Ontology-driven approaches to analyzing data in functional genomics.

Authors:  Francisco Azuaje; Fatima Al-Shahrour; Joaquin Dopazo
Journal:  Methods Mol Biol       Date:  2006

6.  Identification of proteins by their amino acid composition: an evaluation of the method.

Authors:  O Golaz; M R Wilkins; J C Sanchez; R D Appel; D F Hochstrasser; K L Williams
Journal:  Electrophoresis       Date:  1996-03       Impact factor: 3.535

Review 7.  [Information on von Willebrand disease].

Authors:  M Nishino; Y Fujimura
Journal:  Rinsho Byori       Date:  1997-10

8.  Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolism.

Authors:  E Arnaud; V Nicaud; O Poirier; F Rendu; M Alhenc-Gelas; J N Fiessinger; J Emmerich; M Aiach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-02       Impact factor: 8.311

Review 9.  Protease-activated receptors in cardiovascular diseases.

Authors:  Andrew J Leger; Lidija Covic; Athan Kuliopulos
Journal:  Circulation       Date:  2006-09-05       Impact factor: 29.690

Review 10.  Protease-activated receptor signaling: new roles and regulatory mechanisms.

Authors:  Stephen F Traynelis; Joann Trejo
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

View more
  2 in total

1.  Mutation in Rh48: Assessment for possible mutation prone point.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Hematol Blood Transfus       Date:  2010-08-04       Impact factor: 0.900

2.  (pro)renin receptor: A stable molecule.

Authors:  Viroj Wiwanitkit
Journal:  J Nat Sci Biol Med       Date:  2011-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.